A disease’s hidden hand: how Chagas alters drug metabolism
A study in ACS Pharmacology & Translational Science investigates the influence of Chagas disease on the pharmacokinetics of benznidazole in a dog model. Pharmacokinetics, the study of how a drug moves through the body, is a cornerstone of therapeutic drug monitoring (TDM). This research highlights how an underlying parasitic infection can significantly alter the absorption, distribution, metabolism, and excretion of a critical medication, potentially impacting its efficacy and toxicity profile.
Why it might matter to you: For professionals in laboratory medicine, this underscores the complex variables beyond genetics that affect TDM results. It reinforces the need for clinical correlation when interpreting drug levels, as co-morbid infections can be a significant confounder. This finding may influence diagnostic algorithms and the post-analytical interpretation of pharmacokinetic data, ensuring patient-specific factors are fully considered for accurate therapeutic guidance.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
